First-in-Human Experience With a Novel Monorail Microcatheter for Instantaneous Coronary Pressure and Flow Velocity Measurements
Authors' conclusion
In this first-in-human experience, the PyCath microcatheter enabled safe and reproducible measurements of intracoronary pressure and flow velocity with excellent reproducibility.
Study context
- Population
- Patients with a clinical indication for coronary physiology assessment
- Participants
- 17 patients
- Outcome
- Procedural safety (device-related major adverse cardiac events) and device performance (successful acquisition of pressure and velocity signals)
Methodological detailsindependent core laboratory analysis
- Independent core laboratory analysis
Main finding
As reported in the abstract
- Intracoronary pressure measurements feasible
- 100%
- Velocity measurements feasible
- 88%
- Device-related major adverse cardiac events
- There were no device-related major adverse cardiac events
Observational data: associations, not effects.
Further findings
Time required to obtain both measurements
- Mean time
- 70.6 ± 23.6 seconds
Physiology indices
- Mean fractional flow reserve
- 0.84 ± 0.12
- Mean coronary flow velocity reserve
- 2.28 ± 0.79
- Mean hyperemic microvascular resistance
- 1.46 ± 0.77
Test-retest reproducibility (intraclass correlation coefficients)
- Fractional flow reserve ICC
- 0.979 (0.934-0.993)
- Coronary flow velocity reserve ICC
- 0.798 (0.477-0.933)
- Hyperemic microvascular resistance ICC
- 0.759 (0.397-0.919)
- Good-to-excellent
Original publication
First-in-Human Experience With a Novel Monorail Microcatheter for Instantaneous Coronary Pressure and Flow Velocity Measurements. JACC Adv. Published 11 November 2026. doi:10. 1016/ j. jacadv. 2026. 103445
Composed by AI from the published abstract and checked against it. How Briefs are made →